Hookipa Pharma Correlations

HOOK Stock  USD 2.15  0.15  6.52%   
The current 90-days correlation between Hookipa Pharma and Mereo BioPharma Group is 0.25 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hookipa Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hookipa Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Hookipa Pharma Correlation With Market

Modest diversification

The correlation between Hookipa Pharma and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.

Moving together with Hookipa Stock

  0.78ME 23Andme HoldingPairCorr
  0.93VALN Valneva SE ADRPairCorr
  0.78JNJ Johnson Johnson Sell-off TrendPairCorr
  0.87MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.7PFE Pfizer Inc Aggressive PushPairCorr
  0.8IPSC Century TherapeuticsPairCorr
  0.75MTEM Molecular TemplatesPairCorr
  0.93NKTX Nkarta IncPairCorr
  0.78TPST Tempest TherapeuticsPairCorr
  0.86AGL agilon healthPairCorr
  0.79BACK IMAC HoldingsPairCorr
  0.8CYRX CryoportPairCorr
  0.66TCHH Trustcash HoldingsPairCorr
  0.7SHG Shinhan FinancialPairCorr
  0.77EC Ecopetrol SA ADRPairCorr
  0.69HYMTF Hyundai MotorPairCorr
  0.75TLK Telkom Indonesia TbkPairCorr

Moving against Hookipa Stock

  0.64KZR Kezar Life SciencesPairCorr
  0.43MDGL Madrigal PharmaceuticalsPairCorr
  0.42RNXT RenovoRxPairCorr
  0.4MLYS Mineralys Therapeutics,PairCorr
  0.88AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.86T ATT Inc Aggressive PushPairCorr
  0.84CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.81BAC Bank of America Fiscal Year End 10th of January 2025 PairCorr
  0.81INTC Intel Fiscal Year End 23rd of January 2025 PairCorr
  0.79HD Home DepotPairCorr
  0.77HPQ HP IncPairCorr
  0.75CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.7JPM JPMorgan Chase Fiscal Year End 10th of January 2025 PairCorr
  0.5KB KB Financial GroupPairCorr
  0.5VFS VinFast Auto Earnings Call TomorrowPairCorr
  0.45IBM International Business Fiscal Year End 22nd of January 2025 PairCorr
  0.38GE GE Aerospace Fiscal Year End 28th of January 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AMLXELDN
XFORTERN
XFORINZY
INZYMREO
INZYTERN
INZYPDSB
  
High negative correlations   
ELDNINZY
AMLXINZY
AMLXXFOR
AMLXTERN
ELDNTERN
AMLXMREO

Risk-Adjusted Indicators

There is a big difference between Hookipa Stock performing well and Hookipa Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hookipa Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Hookipa Pharma Corporate Management

Lukas FlatzCoFounderProfile
Klaus OrlingerChief OfficerProfile
Reinhard KanderaCFO DirectorProfile
Matthew BeckExecutive RelationsProfile
Mark WinderlichChief OfficerProfile
Joern AldagCEO DirectorProfile
Marine PopoffCommunications MangProfile